AI Insight
Researchers have identified a cell-signaling mechanism by which chronically elevated cholesterol levels promote the enzymatic degradation of LDLR, the receptor responsible for clearing LDL cholesterol from the bloodstream in liver cells. This discovery explains how long-term high cholesterol can paradoxically impair its own removal by reducing the availability of LDLR receptors. Experimental blocking of this degradation enzyme successfully restored LDLR levels in liver cells.
Why it matters
This finding reveals a previously unknown feedback loop that may explain why some patients with chronic high cholesterol respond poorly to conventional treatments. The identification of the specific enzyme involved opens a potential new therapeutic avenue for treating hypercholesterolemia by preventing LDLR degradation rather than solely targeting cholesterol synthesis.
Understand the Science
Nature, Published online: 25 June 2026; doi:10.1038/d41586-026-01899-6
Cholesterol carried by low-density lipoprotein (LDL) drives heart disease and is cleared by liver cells expressing the receptor LDLR. A cell-signalling mechanism has been discovered through which high cholesterol promotes the enzyme-mediated degradation of LDLR. Blocking this enzyme restores LDLR levels in liver cells, suggesting a new strategy for treating high cholesterol.
Source: How long-term dietary cholesterol can slow down its own clearance by liver cells